N-(Ethoxycarbonyl)Piperazine — predicted protein targets

Known targets — ChEMBL curated mechanism

ADRA1A ADRA1B ADRA1D ADRA2A ADRA2B ADRA2C ADRB1 ADRB2 ADRB3 CALCRL CHRM1 CHRM2 CHRM3 F2R MAOA MAOB MAP2K1 MAP2K2 NTRK1 NTRK2 NTRK3 OPRD1 OPRK1 OPRM1 P2RY12 PKLR SCN10A SCN11A SCN1A SCN2A SCN3A SCN4A SCN5A SCN7A SCN8A SCN9A SLC18A2 SLC6A2 SLC6A3 TLR7 TLR9 TUBA1A TUBA1B TUBA1C TUBA3C TUBA3E TUBA4A TUBB TUBB1 TUBB2A TUBB2B TUBB3 TUBB4A TUBB4B TUBB6 TUBB8 dacA dacB dacC folA ftsI mrcA mrcB mrdA pol rplA rplB rplC rplD rplE rplF rplI rplJ rplK rplL rplM rplN rplO rplP rplQ rplR rplS rplT rplU rplV rplW rplX rplY rpmA rpmB rpmB1 rpmB2 rpmC rpmD rpmE rpmE2 rpmF rpmG rpmG1 rpmG2 rpmH rpmI rpmJ rpmJ2 rpsA rpsB rpsC rpsD rpsE rpsF rpsG rpsH rpsI rpsJ rpsK rpsL rpsM rpsN rpsO rpsP rpsQ rpsR rpsR1 rpsR2 rpsS rpsT rpsU rpsZ ykgM ykgO

The experimentally established mechanism targets of N-(Ethoxycarbonyl)Piperazine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 10)

	gene	UniProt	supporting neighbours	confidence
▸	PLAU	P00749	19/20	0.65

▸	PLG	P00747	16/20	0.65

▸	F10	P00742	8/20	0.65

▸	F2	P00734	7/20	0.65

▸	ST14	Q9Y5Y6	7/20	0.65

▸	PLAT	P00750	3/20	0.65

▸	HPN	P05981	3/20	0.65

▸	KLKB1	P03952	1/20	0.65

▸	TPSG1	Q9NRR2	1/20	0.65

▸	HGFAC	Q04756	2/20	0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
N-(Ethoxycarbonyl)Piperazine SCHEMBL1809303	0.99	PLAU (0.67)	PLAUPLGF10F2ST14
N-(Ethoxycarbonyl)Piperazine SCHEMBL2874625	0.91	PLAU (0.80)	PLAUPLGF10F2ST14
N-(Ethoxycarbonyl)Piperazine SCHEMBL4606324	0.90	PLAU (0.80)	PLAUPLGF10F2ST14
N-(Ethoxycarbonyl)Piperazine SCHEMBL2875579	0.88	PLAU (0.61)	PLAUPLGF10F2ST14
Upamostat SCHEMBL12618906	0.88	PLAU (0.84)	PLAUPLGF10F2ST14
Upamostat SCHEMBL20674935	0.88	PLAU (0.84)	PLAUPLGF10F2ST14
Upamostat SCHEMBL30912299	0.88	PLAU (0.84)	PLAUPLGF10F2ST14
N-(Ethoxycarbonyl)Piperazine SCHEMBL2880394	0.87	PLAU (0.63)	PLAUPLGF10F2ST14
N-(Ethoxycarbonyl)Piperazine SCHEMBL3258134	0.86	PLAU (0.51)	PLAUPLGF10F2ST14
N-(Ethoxycarbonyl)Piperazine SCHEMBL3257068	0.85	PLAU (0.52)	PLAUPLGF10F2ST14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20080058346-A1	Crystalline Modifications of N-Alpha-(2,4,6-Triisopropylphenylsulfonyl)-3-Hydroxyamidino- (L)- Phenylalanine 4-Ethoxycarbonylpiperazide And/Or Salts Thereof	WILEX AG (DE)	2008-03-06	—	—	US	claimed
US-8492385-B2	Crystalline modifications of N-alpha-(2,4,6-triisopropylphenylsulfonyl)-3-hydroxyamidino- (L)- phenylalanine 4-ethoxycarbonylpiperazide and/or salts thereof	WILEX AG (DE)	2013-07-23	—	—	US	disclosed
US-20100266679-A1	CRYSTALLINE MODIFICATIONS OF N-ALPHA-(2,4,6-TRIISOPROPYLPHENYLSULFONYL)-3-HYDROXYAMIDINO- (L)- PHENYLALANINE 4-ETHOXYCARBONYLPIPERAZIDE AND/OR SALTS THEREOF	GRUNENBERG ALFONS	2010-10-21	—	—	US	disclosed
US-7713980-B2	Crystalline modifications of N-α-(2,4,6-triisopropyl-phenylsulfonyl)-3-hydroxyamidino-(L)- phenylalanine 4-ethoxycarbonylpiperazide and/or salts thereof	WILEX AG (DE)	2010-05-11	—	—	US	disclosed
US-20080058346-A1	Crystalline Modifications of N-Alpha-(2,4,6-Triisopropylphenylsulfonyl)-3-Hydroxyamidino- (L)- Phenylalanine 4-Ethoxycarbonylpiperazide And/Or Salts Thereof	WILEX AG (DE)	2008-03-06	—	—	US	disclosed